Colorectal Cancer: Does Continuing Induction Chemo Do Any Good?
Study compares strategies in metastatic disease
Related Articles
Opinion | Diversity Action Plans for Clinical Trials: Evaluating FDA’s Draft Guidance
A critical analysis reveals opportunities and challenges prior to finalization
West Nile and EEE: What to Know About Mosquito-Borne Illness in the U.S.
These diseases may be causing a buzz, but they’re not doing anything unusual this season
Opinion | I’ve Seen the Extreme Pain of IUD Insertion
CDC’s new guidance is a good first step, but more is needed to acknowledge women’s pain
Hepatocellular Carcinoma Incidence is Decreasing Among Younger Adults in the United States
Incidence rates for hepatocellular carcinoma (HCC) increased rapidly in the U.S. since the 1990s, but have plateaued or started to decrease in other industrialized countries.
Which Vaccines Should You Get and Recommend This Fall?
Paul Offit, MD, talks about the flu, RSV, and COVID vaccines for the 2024-2025 season
Tennessee Medical Board Refuses to Enforce New IMG Law
Members skeptical of verification process, concerned about patient safety
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
Having a medical condition was tied to increased risk of suicide in a dose-response-like manner
Novel Smart Mask Monitors Exhaled Breath Continuously
Immediate clinical application is unclear, but prototype shows potential
Rheumatological Conditions as Risk Factors for Self-Harm: A Retrospective Cohort Study
To examine the risk of self‐harm in rheumatological conditions Retrospective cohort study using data from the Clinical Practice Research Datalink. Patients with ankylosing spondylitis, fibromyalgia,…
Should Intensified Infliximab for Refractory Acute Severe UC Be Nixed?
PREDICT-UC trial found no benefit with intensified or accelerated regimens
